Merrimack Pharmaceuticals revenue increased from $89.3 million in 2015 to $144.3 million in 2016, a (61.6%) increase.

Annual Revenue ($)

Merrimack Pharmaceuticals revenue was $144.27 m in FY, 2016 which is a (61.6%) year over year increase from the previous period.

Quarterly Revenue ($)

FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016
Revenue$48.92 m$47.79 m$102.76 m$89.26 m$144.27 m
Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016
Revenue$11.34 m$12.06 m$11.32 m$14.66 m$18.45 m$6.86 m$13.03 m$27.82 m$28 m$14.84 m$36.56 m$16.44 m$21.28 m$33.68 m$28.07 m

Annual Growth Rate (%)

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu